[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.203.245.76. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
Health Care Policy and Law
February 2017

The Use of Public Health Evidence in Whole Woman’s Health v Hellerstedt

Author Affiliations
  • 1Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California–San Francisco, San Francisco
 

Copyright 2017 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2017;177(2):155-156. doi:10.1001/jamainternmed.2016.6839

Enacted in 2013, Texas’s House Bill 2 (HB 2) was one of the most restrictive abortion laws in the country. The law had 4 provisions: (1) physicians providing abortion had to have admitting privileges at nearby hospitals, (2) medication abortion had to be provided according to the protocol described in the US Food and Drug Administration (FDA)-approved labeling of mifepristone, (3) most abortions at 20 weeks postfertilization or later were banned, and (4) facilities providing abortion had to meet the standards of ambulatory surgical centers. The first 3 provisions went into effect by November 2013; the fourth provision, meeting the standards of ambulatory surgical centers, was enforced only briefly in October 2014 before the US Supreme Court issued a stay.

×